Macy's Bold New Chapter: 14 More Stores Closing as Retail Giant Doubles Down on Turnaround
Macy's is shuttering 14 stores across 12 states as part of its 'Bold New Chapter' strategy. Here's why the 125-year-old retailer is shrinking to survive.
3286 articles found for "investing"
Wall Street's Confidence Problem: Record Bullish Positioning May Signal Trouble Ahead
With leveraged long positions in the Russell 2000 at the 94th percentile and markets at record highs, some strategists warn investors may be too complacent.
Aktis Oncology Breaks the IPO Drought: First Biotech of 2026 Raises $318 Million
Radiopharmaceutical developer Aktis Oncology raised $318 million in the first biotech IPO of 2026, with Eli Lilly taking a $100 million stake. The strong debut signals renewed investor appetite for biotech risk.
The Buffett Indicator Hits Record Highs: Why Warren Buffett's Favorite Metric Is Flashing Warning Signs
Warren Buffett's favorite market metric has hit 224%, the highest level ever recorded. Here's what it means for investors and why timing matters less than you think.
Bitcoin's 2026 Outlook: Why Experts Predict BTC Could Swing From $75,000 to $225,000
Industry executives and analysts forecast Bitcoin could trade anywhere from $75,000 to $225,000 in 2026, reflecting the extreme volatility that continues to define the asset class.
Semiconductor Stocks Surge as Industry Approaches Historic $1 Trillion Sales Milestone
Chip stocks rallied to kick off 2026 as Bank of America forecasts the semiconductor industry will finally cross $1 trillion in annual sales. Here are the stocks leading the charge.
Regional Banks Are Back: Why Small and Mid-Size Lenders Are Outperforming in 2026
Regional bank stocks are leading the financial sector in early 2026 as Fed rate cuts improve net interest margins and deregulation expectations fuel a wave of M&A activity.
JPMorgan Healthcare Conference 2026: The Biggest Week in Biotech Begins Monday
The 44th annual JPMorgan Healthcare Conference kicks off Monday in San Francisco. Here's what biotech and pharma investors need to watch.
Dow Crosses 49,000: The Blue-Chip Renaissance Reshaping Wall Street
The Dow Jones Industrial Average has crossed 49,000 for the first time, driven by a rotation into 'old economy' stocks. Here's what's behind the blue-chip renaissance.
Small-Cap Renaissance: Russell 2000 Surges to Record Highs as 'Great Rotation' Gains Momentum
The Russell 2000 hit new all-time highs as investors rotate out of big tech and into small-cap stocks. The 'January Effect' is in full swing with the index up over 6% in the first week of 2026.
The Great Reversal: International Stocks Crushed U.S. Markets in 2025
After a decade of U.S. dominance, international stocks outperformed by nearly 13 percentage points in 2025. Here's what drove the shift and what it means for 2026.
Nvidia's $500 Billion Pipeline: Why Wall Street Sees the AI Chip King Extending Its Dominance
Nvidia has visibility to half a trillion dollars in revenue through 2026 from its Blackwell and Rubin platforms. As the AI chip king prepares for CES, analysts see continued dominance ahead.